Advances and applications of chiral resolution in pharmaceutical field-Reference-Cited by-同舟云学术

Advances and applications of chiral resolution in pharmaceutical field

Published:2022-06-08 Issue:8 Volume:34 Page:1094-1119
ISSN:0899-0042
Container-title:Chirality
language:en
Short-container-title:Chirality

Author:

Teng Yan¹,Gu Chenglu¹,Chen Zhuhui¹,Jiang Hui¹,Xiong Yue¹,Liu Dong²,Xiao Deli¹³⁴^ORCID

Affiliation:

1. Department of Analytical Chemistry China Pharmaceutical University Nanjing China

2. Anhui Engineering Laboratory for Conservation and Sustainable Utilization of Traditional Chinese Medicine Resources, School of Biological and Pharmaceutical Engineering West Anhui University Liu'an China

3. Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University) Ministry of Education Nanjing China

4. Key Laboratory of Biomedical Functional Materials China Pharmaceutical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Pharmacology,Catalysis,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/chir.23453

Reference197 articles.

1. Chiral drugs: an overview;Nguyen L;Int J Biomed Sci,2006

2. Processes To Separate Enantiomers

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral Covalent Organic Frameworks as Promising Materials for Racemate Resolution;ACS Applied Polymer Materials;2024-07-22

2. Paper-based optical sensor arrays for simultaneous detection of multi-targets in aqueous media: A review;Analytica Chimica Acta;2024-07

3. Chiral drugs: Sources, absolute configuration identification, pharmacological applications, and future research trends;LabMed Discovery;2024-07

4. Beyond conventional: Role of chiral metal–organic frameworks in asymmetric scenarios;Nano Today;2024-06

5. Enantiomeric resolution of three profen drugs using direct thin-layer chromatographic method;JPC – Journal of Planar Chromatography – Modern TLC;2024-06